To the FDA: Approve Leronlimab Now for Critically Ill COVID-19 Patients – Article by Dan Elton
Daniel C. Elton, Ph.D. Author’s Note: This article is cross-posted from my Substack. How does Leronlimab work? Leronlimab is a humanized monoclonal antibody that antagonistically binds to the CCR5 receptor to block activation of immune cells and lower the release of cytokines. The development of Leronlimab started with mouse antibodies that bind to CCR5….